Their enhanced activity was demonstrated in colonic biopsy taken from IBD patients, and treatment with inhibitors for MAPK pathway ameliorated pro-inflammatory cytokine levels (e.g. TNFα) and disease activity index leading to endoscopic improvement [101, 102]. This evidence concerns the gene TNF and inflammatory bowel disease.